Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Lokivetmab reduced itching in a dog with skin lymphoma.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The treatment is safe and shows promise for metastatic breast cancer.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Promising cancer treatments were found, but the manufacturer closed.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Entospletinib effectively prevents eye and skin GVHD in mice.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The treatment was ineffective in humans.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.